Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $18.0000 (4.05%) ($17.0000 - $18.0000) on Mon. Feb. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.25% (three month average) | RSI | 61 | Latest Price | $18.0000(4.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -0.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TBT(9%) EWG(8%) PEJ(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.625% in a week (0% probabilities). TLT(-9%) GLD(-9%) SLV(-8%) GDX(-8%) SIL(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.625% (StdDev 5.25%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
5 Day Moving Average | $17.92(0.45%) | 10 Day Moving Average | $18.43(-2.33%) | 20 Day Moving Average | $17.89(0.61%) | To recent high | -34.5% | To recent low | 23.3% | Market Cap | $355m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |